Friday, June 11, 2021

Janux Therapeutics Prices IPO, Hits Nasdaq Today

La Jolla-based biopharmaceuticals startup Janux Therapeutics said early this morning that it has priced its IPO, offering up 11,400,000 shares of its common stock at $17.00 per share. The company begins trading this morning on the Nasdaq Global market under the ticker symbol JANX. According to the company, the gross proceeds from the effort are expected to be $193.8M. Janux Therapeutics is

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.